These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Third biannual report of the Cochrane Haematological Malignancies Group. Kober T; Skoetz N; Trelle S; Bohlius J; Engert A; J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014 [No Abstract] [Full Text] [Related]
5. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients. Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Wirk B; Fenske TS; Hamadani M; Zhang MJ; Hu ZH; Akpek G; Aljurf MD; Armand P; Ayala E; Bachanova V; Bolwell B; Cairo MS; Cashen A; Chen YB; Costa LJ; Farhan S; Freytes CO; Gajewski JL; Gibson J; Hale GA; Holmberg LA; Hsu JW; Inwards DJ; Kamble RT; Maharaj D; Maziarz RT; Munker R; Nath R; Reddy NM; Reeder CB; Rizzieri DA; Sauter CS; Savani BN; Schouten HC; Sureda A; Vose JM; Waller EK; Wiernik PH; Gale RP; Burns LJ; Saber W Biol Blood Marrow Transplant; 2014 Jul; 20(7):951-9. PubMed ID: 24641828 [TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party. Bento L; Boumendil A; Finel H; Le Gouill S; Amorim S; Monjanel H; Bouabdallah R; Bay JO; Nicolas-Virelizier E; McQuaker G; Rossi G; Johnson R; Huynh A; Ceballos P; Rambaldi A; Bachy E; Malladi R; Orchard K; Pohlreich D; Tilly H; Bonifazi F; Poiré X; Guilhot F; Haenel A; Crawley C; Metzner B; Gribben J; Russell NH; Damaj G; Thomson K; Dreger P; Montoto S Bone Marrow Transplant; 2017 Aug; 52(8):1120-1125. PubMed ID: 28530668 [TBL] [Abstract][Full Text] [Related]
8. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B. Nademanee A; Forman SJ Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658 [TBL] [Abstract][Full Text] [Related]
9. Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma. Vose JM; Bierman PJ; Lynch JC; Weisenburger DD; Kessinger A; Chan WC; Greiner TC; Armitage JO J Clin Oncol; 1998 Mar; 16(3):844-9. PubMed ID: 9508164 [TBL] [Abstract][Full Text] [Related]
10. Transplantation strategies for patients with follicular lymphoma. Buske C; Dreyling M; Unterhalt M; Hiddemann W Curr Opin Hematol; 2005 Jul; 12(4):266-72. PubMed ID: 15928482 [TBL] [Abstract][Full Text] [Related]
11. Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma. Krishnan A; Nademanee A; Fung HC; Raubitschek AA; Molina A; Yamauchi D; Rodriguez R; Spielberger RT; Falk P; Palmer JM; Forman SJ J Clin Oncol; 2008 Jan; 26(1):90-5. PubMed ID: 18025438 [TBL] [Abstract][Full Text] [Related]
12. Hematopoietic cell transplantation for lymphomas. Ayala E; Tomblyn M Cancer Control; 2011 Oct; 18(4):246-57. PubMed ID: 21976243 [TBL] [Abstract][Full Text] [Related]
13. The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma. Villanueva ML; Vose JM Clin Adv Hematol Oncol; 2006 Jul; 4(7):521-30. PubMed ID: 17147239 [TBL] [Abstract][Full Text] [Related]
14. Transformation in follicular lymphoma: biology, prognosis, and therapeutic options. Wong E; Dickinson M Curr Oncol Rep; 2012 Oct; 14(5):424-32. PubMed ID: 22865028 [TBL] [Abstract][Full Text] [Related]
15. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma]. Ogura M Rinsho Ketsueki; 2008 Oct; 49(10):1434-50. PubMed ID: 18833928 [No Abstract] [Full Text] [Related]
16. Histologic transformation of follicular lymphoma after allogeneic bone marrow transplantation. Kojima K; Mannami T; Yoshino T; Kawasaki H; Sasaki K; Maeda T; Furuya K; Harada M; Hara M Bone Marrow Transplant; 2000 Sep; 26(5):581-3. PubMed ID: 11019852 [TBL] [Abstract][Full Text] [Related]
17. Development of diffuse large B-cell lymphoma from duodenal type follicular lymphoma: a retrospective study of 23 cases. Saburi M; Kondo Y; Ogata M; Soga Y; Abe M; Takano K; Kohno K; Nagai T; Nakayama T Int J Hematol; 2020 Nov; 112(5):658-665. PubMed ID: 32740764 [TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy followed by autologous and allogeneic hematopoietic stem cell transplantation in patients with follicular non-Hodgkin’s lymphoma in the rituximab era. Escobar IG; Sánchez de Ibarguen BC; de Juan VC; Alonso CM; García MM; Ruíz AC; Pulla MP Tumori; 2015; 101(1):2-7. PubMed ID: 25702654 [TBL] [Abstract][Full Text] [Related]
20. Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma. Derenzini E; Musuraca G; Fanti S; Stefoni V; Tani M; Alinari L; Venturini F; Gandolfi L; Baccarani M; Zinzani PL Cancer; 2008 Nov; 113(9):2496-503. PubMed ID: 18833583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]